NovaBridge Biosciences (NBP) — Cash Flow Quality Index

Latest as of December 2020: -19.06x

NovaBridge Biosciences (NBP) has a Cash Flow Quality Index of -19.06x as of December 2020. Operating cash flow of $-232.84 Million is below net income of $12.22 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NovaBridge Biosciences (NBP) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-19.06x
Operating CF / Net Income

Operating Cash Flow

$-232.84 Million
USD

Net Income

$12.22 Million
USD

Data as of

Dec 2020
Most recent filing

NovaBridge Biosciences Cash Flow Quality Index (2020–2020)

Historical Cash Flow Quality Index for NovaBridge Biosciences across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of NovaBridge Biosciences to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for NovaBridge Biosciences (2020–2020)

Year-by-year earnings quality comparison for NovaBridge Biosciences. For live market cap and the full company financial profile, see market cap of NovaBridge Biosciences.

Year Quality Index Operating CF (USD) Net Income YoY Change
2020 0.92x $433.56 Million $470.92 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.